# SCBIO

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/scbio

- Industry: Biotechnology
- Headquarters: Daejeon, South Korea
- Website: www.sc-bio.co.kr
- Total disclosed funding: $8.3M
- Latest round: Series A (May 18, 2023)
- Investors on record: 9

## About

Founded in 2021, and based in Daejeon, South Korea, SCBIO Inc. operates as a biotechnology company that is involved in the research on cancer-related diseases with the goal of developing anticancer drugs. In August 2022, SCBIO Inc. raised KRW 6 billion in Pre-Series A funding from Magna Investments, L&S Venture Capital, Korea University Technology Holdings, Korea Technology Finance Corporation, etc. In May 2023, SCBIO Inc. raised KRW 11 billion in series A funding from new investors T.S. Investment, LSK Investment, Industrial Bank of Korea, Holistic Growth Initiative, Daesung Startup Investment, and A Ventures, with participation from returning investors Magna Investments, L&S Venture Capital, and Korea Science & Technology Holdings. also participated in this round. As of August 2022, the firm is being led by Lee Chang-hoon as its CEO and employs over 20 professionals.

The firm develops low-molecular compound immunotherapy drugs namely SCB001 and SCB002 that regulate immune cell activity in tumors to produce anti-cancer efficacy, and is especially helpful in treating pancreatic cancer.

The company intends to use the August 2022 funding to continue the research and development of its lead projects, 'SCB001' and 'SCB002'.

The company will use the May funding to spur preclinical trials for SCB002 and SCB001, and clinical development costs for IND approval.

## Funding rounds

- Series A, May 18, 2023, $8.3M — Industrial Bank of Korea, Daesung Private Equity, L&S Venture Capital, Magna Investment, T.S. Investment, Holistic Growth Initiative, LSK Investment, A Ventures, Korea Science & Technology Holdings

## Investors

- Industrial Bank of Korea — Series A
- Daesung Private Equity (https://capitalatlas.ai/funds/daesung-private-equity) — Series A
- L&S Venture Capital (https://capitalatlas.ai/funds/l-s-venture-capital) — Series A
- Magna Investment (https://capitalatlas.ai/funds/magna-investment) — Series A
- T.S. Investment (https://capitalatlas.ai/funds/t-s-investment) — Series A
- Holistic Growth Initiative (https://capitalatlas.ai/funds/holistic-growth-initiative) — Series A
- LSK Investment (https://capitalatlas.ai/funds/lsk-investment) — Series A
- A Ventures — Series A
- Korea Science & Technology Holdings — Series A